Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 30.38M P/E - EPS this Y 7.20% Ern Qtrly Grth -
Income -48.93M Forward P/E -0.84 EPS next Y - 50D Avg Chg -25.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -31.00%
Dividend N/A Price/Book 0.86 EPS next 5Y - 52W High Chg -67.00%
Recommedations 2.00 Quick Ratio 2.80 Shares Outstanding 5.47M 52W Low Chg 53.00%
Insider Own 0.31% ROA -72.22% Shares Float 4.99M Beta 1.72
Inst Own 13.68% ROE -171.26% Shares Shorted/Prior 63.89K/62.84K Price 7.97
Gross Margin - Profit Margin - Avg. Volume 372,934 Target Price -
Oper. Margin - Earnings Date May 14 Volume 6,924 Change -1.60%
About Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It develops Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease; and is in phase 2 clinical development for the treatment of non-alcoholic steatohepatitis (NASH), as well as preclinical studies of Rencofilstat shows reduction in liver fibrosis, liver inflammation, liver tumor burden, and titers of HBV, HCV, HDV, and HIV-1, and has demonstrated antiviral activities for hepatitis B, C, and D viruses through several mechanisms. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey.

Hepion Pharmaceuticals, Inc. News
04/19/24 Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial
03/06/24 Hepion Pharmaceuticals Strengthens Board of Directors with Appointment of Michael Purcell
02/16/24 Hepion Pharmaceuticals Announces Exercise of Warrants for Approximately $2.0 Million Aggregate Gross Proceeds
01/03/24 Hepion Pharmaceuticals to Present at NASH-TAG 2024
12/07/23 Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes
11/28/23 Hepion Pharmaceuticals to Present at the 7th Obesity & NASH Drug Development Summit
11/13/23 Hepion Pharmaceuticals Announces Major Reductions in Liver Stiffness with Rencofilstat Treatment in 17-week Phase 2 Study of Advanced (F3) MASH Liver Disease
11/10/23 Hepion Pharmaceuticals Schedules Conference Call to Review Additional Efficacy Data from Phase 2 ‘ALTITUDE-NASH’ Liver Function Trial of Rencofilstat
10/25/23 Hepion Pharmaceuticals’ Rencofilstat Demonstrates Anti-Cancer Activity in Hepatitis C-Associated Cancer Model
09/29/23 Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
09/21/23 Hepion Pharmaceuticals to Participate in 2023 Cantor Global Healthcare Conference
09/21/23 New Anti-Cancer Opportunities Revealed for Hepion Pharmaceuticals’ Rencofilstat in Cancer Screening Program
09/19/23 Here's Why Hepion Pharmaceuticals (NASDAQ:HEPA) Must Use Its Cash Wisely
09/19/23 Hepion Pharmaceuticals Discovers Novel Rencofilstat Action in Liver Cancer
09/18/23 Insider Buying: Robert Foster Acquires 1,600 Shares of Hepion Pharmaceuticals Inc
07:45 AM Rencofilstat Produces Positive Outcomes in Translational Study on Idiopathic Pulmonary Fibrosis
09/06/23 Hepion Pharmaceuticals Announces Management Changes
06/15/23 Hepion Pharmaceuticals to Present Two Posters at EASL International Liver Congress™ 2023
06/15/23 Hepion Pharmaceuticals Announces Passing of Key Safety Milestone in Phase 2b ‘ASCEND-NASH’ Trial of Rencofilstat
05/24/23 Hepion Pharmaceuticals to Highlight AI-POWR™ at the 2023 CSPS Annual Symposium: The Next Frontiers in Pharmaceutical Sciences
HEPA Chatroom

User Image Tacto Posted - 7 hours ago

$HEPA Hepion contracted out to API for much of what they did over the years. It's not new. The close connections have always been there, and Foster was on their SAB for many years. What Hepion did recently is migrate most of their employees directly to API. We posted a lot about API on this forum, some years ago, as many of you will recall. API sure has expanded since then, by a heck of a lot..

User Image 5xStarTrader Posted - 10 hours ago

$HEPA So, Armistice knew about the API connection, as well as John Brancaccio, Peter Wjingaard, Timothy Block & Kaouthar Lbiati, because Hepion COO Launa Aspeslet is Board Chairman of API. Where the Chairman has a lot of influence among a vast network of clients and prospective suitors. Remarkably, all of Hepion's core Team Members who left so Hepion could conserve cash (to allow adequate time for Michael Purcell to execute on plan "to enhance shareholder value") are all currently on staff at API. And API provides services to biotech companies, which services are basically all designed "to enhance shareholder value."

User Image xx007xx Posted - 12 hours ago

$HEPA so you’re pro $AUPH now and taking over your shares for a penny on the dollar you invested here? I don’t believe you have a position here

User Image 5xStarTrader Posted - 13 hours ago

$HEPA Is API just doing what it claims is its specialty of providing services by "helping" Hepion and some as yet unidentified Partner, or Suitor, to succeed while Hepion prudently cuts costs to protect investors by extending the cash runway? Wherein API is simply performing per terms of an agreement with the suitor to pay the salaries of the Hepion Team (they've agreed to reimburse?), so that all of the enormous talent represented by the Hepion Team stays onboard? That would provide a service in accordance with API's specialty while Michael Purcell works out the financial terms of the deal with the suitor or partner, which would make a lot of sense.

User Image 5xStarTrader Posted - 13 hours ago

$HEPA I was just reading on API's website about "What we do" and one thing they don't do is buy other companies. Their specialty is helping biotech companies succeed at everything. https://appliedpharma.ca/service/partnership-generation/

User Image 5xStarTrader Posted - 14 hours ago

$HEPA There are too many people involved with Hepion for years that have very prestigious careers for there to be intentional fraud involved, IMHO. The late Stephen Harrison founder of world wide Summit Clinics is but one example of some of the top caliber people involved. Hepion COO Launa Aspeslet is the Chairman of API and next to her is a Nobel Laureate Chief Scientific Officer, Sir Michael Houghton. So, I'm not buying the idea that there is a vast conspiracy to defraud shareholders; that just makes no sense. Did Armistice invest $12 million in Hepion on a whim when they've been involved with AUPH for years and know all the players at Hepion & Aurinia? Is Michael Purcell knowingly ruining his career and risking jail just for the fun of being involved in a fraud to cheat investors? As they say, that bag just doesn't hold water. Armistice is expecting a ROI and so is Peter Wjingaard and John Brancaccio, Timothy Block, Kaouthar Lbiati & Gary Jacob...as well as Michael Purcell.

User Image kenny91655 Posted - 15 hours ago

$HEPA The investigation should have happened during and before ownership in the stock. After delaying and missing milestones they had set along with management and board members that were tied to other BK companies. A RS, no qualified institutional investors, previous large investors that were tied to scams and serial pumpers. It should have been a red flag

User Image xx007xx Posted - 15 hours ago

$HEPA there needs to be a serious investigation and suit into the screwing of retail and soon to be acquisition by $AUPH due to how many former employees went over there to continue the development while screwing the majority of shareholders here. Absolutely criminal

User Image xx007xx Posted - 15 hours ago

$HEPA $AUPH is going. To screw us

User Image xx007xx Posted - 15 hours ago

$HEPA pure trash. Worst placement of money in my life. Never again.

User Image onetimeengineer Posted - 15 hours ago

$HEPA No surprise.

User Image PharmHand Posted - 15 hours ago

$HEPA And down goes Frazier!

User Image 5xStarTrader Posted - 16 hours ago

$HEPA API also lists Hepion's COO Launa Aspeslet as API Board Chairman, which is another notable coincidence.

User Image iceman36 Posted - 16 hours ago

$HEPA notable that almost the entire past R&D team is working at API now. Mayo, Ure, and trepanier in addition to all research scientists and pharmacologists.

User Image 5xStarTrader Posted - 17 hours ago

$HEPA Come on Mike Purcell!! Deliver the Bigly "SOLD!!! To the highest bidder for $$$$$$$$ !!!

User Image Tacto Posted - 19 hours ago

$HEPA @StupediaTrades If you own a lot of orange juice at the moment, you're in tall cotton. If you don't, you're sleeping on the job..

User Image Craigmack187 Posted - 1 day ago

$HEPA how long before they go under?

User Image lifescience_investor Posted - 2 days ago

@Bunster @5xStarTrader He ended up blocking me lol Wesley Thompson will have no rain on his Disneyland parade, that's for sure! $HEPA

User Image lifescience_investor Posted - 2 days ago

$HEPA @BADBOYROY When you're right, you're right!

User Image WindyCityDreamz Posted - 3 days ago

$HEPA no such thing as green here

User Image BADBOYROY Posted - 3 days ago

$HEPA anyone notice that @InvestorKong showed up just as @Tacto began to lose his control over the board? I fell to both ruses. Too much inside info from those claiming to not be insiders. Kong changed his tune from an investment firm watching the algo trade, to insider with privileged knowledge. Well played gentlemen.

User Image mahaparinirvan Posted - 3 days ago

$HEPA They pushed out the toilet flush to next week.. Not sure why.. But sure its coming next week

User Image StupediaTrades Posted - 3 days ago

$HEPA Positive spin .This stock is now stress free as anyone stuck in it from Bio Crash has lost everything possible already so any plus here is a victory . You are most welcome. Happy Friday

User Image RyGuyBoom Posted - 3 days ago

$HEPA Earthquake aftershock...

User Image RyGuyBoom Posted - 3 days ago

$HEPA Is the SP earthquake over...?

User Image YoungTJ Posted - 3 days ago

$HEPA you’re gunna love this at $1, easy buy!!!

User Image mahaparinirvan Posted - 3 days ago

$HEPA Its obvious they will cover the next batch of short at a new ATL… Coming next week

User Image LousiaG2021 Posted - 3 days ago

$HEPA $AUPH

User Image YoungTJ Posted - 3 days ago

$HEPA sell it for $5 a share idc anymore

User Image baurzhan16 Posted - 4 days ago

$HEPA do you know some bio BO cases where SP went from single digit to triple digits ? (Because of bo)🤔

Analyst Ratings
Brookline Capital Hold Dec 7, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Wijngaard Peter Director Director Nov 24 Buy 3.07 5,000 15,350 9,501 11/28/23
Wijngaard Peter Director Director Sep 15 Buy 5.57 3,000 16,710 4,501 09/20/23
Foster Robert T CEO and Director CEO and Director Sep 18 Buy 5.60 1,600 8,960 50,470 09/19/23
Foster Robert T CEO,CSO and Director CEO,CSO and Director Sep 15 Buy 5.40 1,600 8,640 48,870 09/18/23